Daewon Pharmaceutical Co., Ltd. (KRX:003220)
South Korea · Delayed Price · Currency is KRW 7,650.00
-230.00 (-2.92%)
Oct 15, 2026, 11:59 AM KST
Daewon Pharmaceutical Market Cap
Daewon Pharmaceutical has a market cap or net worth of 163.97 billion as of October 14, 2026. It is the 23,971st most valuable company in the world and the 968th biggest in South Korea. Its market cap has decreased by 41.06% in one year.
Market Cap
163.97B
Enterprise Value
294.98B
Revenue
614.64B
Global Rank
Country Rank
#968 South Korea
PE Ratio
39.16
ChartMarket Cap Chart
Since March 1, 2001, Daewon Pharmaceutical's market cap has increased from 18.06B to 163.97B, an increase of 807.90%. That is a compound annual growth rate of 8.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 163.97B | -35.98% |
| Dec 30, 2025 | 256.13B | -16.14% |
| Dec 30, 2024 | 305.43B | -7.98% |
| Dec 28, 2023 | 331.93B | -15.58% |
| Dec 29, 2022 | 393.20B | 14.64% |
| Dec 30, 2021 | 343.00B | -9.91% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Whan In Pharm | 191.49B |
| AptaBio Therapeutics | 186.82B |
| REYON Pharmaceutical | 182.68B |
| Yungjin Pharm. | 182.16B |
| Chong Kun Dang Holdings | 176.85B |
| FutureChem Co.,Ltd | 175.43B |
| Samil Pharmaceutical Co.,Ltd | 168.19B |
| JW Lifescience | 165.22B |